Last news
Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

...

HanoiPlasPrintPack Exhibition will Physically Return from 8-11/6 to Drive Industrial Transformation and Upgrades

HanoiPlasPrintPack Exhibition will Physically Return from 8-11/6 to Drive Industrial Transformation and Upgrades

...

European business communications provider Dstny refinances existing debt to fuel further expansion

European business communications provider Dstny refinances existing debt to fuel further expansion

...

Chubb Establishes Aviation Hub in Singapore

Chubb Establishes Aviation Hub in Singapore

...

Florasis - The Only Chinese Brand Being Invited to Participate in the World's Top Fashion Forum

Florasis - The Only Chinese Brand Being Invited to Participate in the World's Top Fashion Forum

...

American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian

American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian

...

U.S. Institute of Peace Opens Nominations for 2023 Women Building Peace Award

U.S. Institute of Peace Opens Nominations for 2023 Women Building Peace Award

...

Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough

Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough

...

menu
menu